Endoscopic sinus surgery in the treatment of cystic fibrosis with nasal polyposis

Laryngoscope

Volumn 106, Issue 12, 1996, Pages 1540-1544

  Rowe Jones, Julian M ^a   Mackay, Ian S ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN;

ARTICLE; CELL MEMBRANE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MALE; NOSE POLYP; NOSE SEPTUM RECONSTRUCTION; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RHINORRHEA; SINUSITIS; TREATMENT PLANNING;

EID: 0029804588     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199612000-00019     Document Type: Article

References (32)

1. Super M. The gene defect in cystic fibrosis and clinical applications of the knowledge. J R Soc Med. 1992;85(suppl 19):6-8.
2. Alton EW, Currie D, Logan-Sinclair R, et al. Nasal potential difference: a clinical diagnostic test for cystic fibrosis. Eur Respir J. 1990;3:922-926.
3. Welsh MJ, Smith, AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993;73: 1251-1254.
4. Welsh MJ, Smith, AE. Cystic fibrosis. Scientific American. 1995;273:36-43.
5. Anderson, MP, Welsh, MJ. Calcium and cAMP activate different chloride channels in the apical membrane of normal and cystic fibrosis epithelia. Proc Natl Acad Sci USA. 1991;88: 6003-6007.
6. Clarke LL, Grubb BR, Yankashan JR, et al. Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in CFTR (-/-) mice. Proc Natl Acad Sci U S A. 1994;91:479-483.
7. Rozmahel R, Wilschanski M, Matin A, et. al. Modulation of disease severity in cystic fibrosis conductance regulator-deficient mice by a secondary genetic factor. Nat Genet. 1996; 12:280-287.
8. Cuthbert AW. The biochemical defect in cystic fibrosis. J R Soc Med. 1992;85(suppl 19):2-5.
9. Rutland J, Cole PJ. Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis. Thorax. 1981;36:654-658.
10. Potter JL, Spector S, Matthews LW, et al. Studies on pulmonary secretions, III: the nucleic acids in whole pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy. Am Rev Respir Dis. 1969;99:909-916.
11. Oppenheimer EH, Rosenstein BJ. Differential pathology of nasal polyps in cystic fibrosis and atopy. Lab Invest. 1979; 40:445-449.
12. Sørensen H, Mygind N, Tygstrup I, et al. Histology of nasal polyps of different etiology. Rhinology. 1977;15:121-128.
13. Slavit DH, Kasperbauer JL. Ciliary dysfunction syndrome and cystic fibrosis. In: McCaffrey TV, ed. Systemic Disease and the Nasal Airway. 1st ed. New York: Thieme; 1993: 131-149.
14. Chow CW, Landau LI, Taussig LM. Bronchial mucous glands in the newborn with cystic fibrosis. Eur J Pediatr. 1982;139: 240-243.
15. Cuyler JP, Monaghan AJ. Cystic fibrosis and sinusitis. J Otolaryngol. 1989;18:173-175.
16. Neely JG, Harrison GM, Jerger JF, et al. The otolaryngologic aspects of cystic fibrosis. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:313-324.
17. Shwachman H, Kulczycki L, Mueller H, et al. Nasal polyps in patients with cystic fibrosis. Pediatrics. 1962;30:389-401.
18. Stern RC, Boat TF, Wood RE, et al. Treatment and prognosis of nasal polyps in cystic fibrosis. Am J Dis Child. 1982;135: 1067-1070.
19. Kerrebijn JDF, Poublon RML, Overbeek SE. Nasal and paranasal disease in adult cystic fibrosis. Eur Respir J. 1992;5:1239-1242.
20. Brihaye P, Clement PAR, Dab I, et al. Pathological changes of the lateral nasal wall in patients with cystic fibrosis. Int J Pediatr Otorhinolaryngol. 1994;28:141-147.
21. Coste A, Gilain L, Roger G, et al. Endoscopic and CT-scan evaluation of rhinosinusitis in cystic fibrosis. Rhinology. 1995; 33:152-153.
22. Jaffe BF, Strome M, Khaw K-T, et al. Nasal polypectomy and sinus surgery for cystic fibrosis: a 10-year review. Otolaryngol Clin North Am. 1977;10:81-90.
23. Britton JR. Effects of social class, sex and region of residence on age at death from cystic fibrosis. Br Med J. 1989;298:483-487.
24. Lewis PA. The epidemiology of cystic fibrosis. In: Hudson ME, Geddes DM, eds. Cystic Fibrosis. 1st ed. London: Chapman and Hall; 1995;1-13.
25. Lund VJ, Mackay IS. Staging in rhinosinusitis. Rhinology. 1993;31:183-184.
26. Duplechain JK, White JA, Miller RH. Pediatric sinusitis: the role of endoscopic sinus surgery in cystic fibrosis and other forms of sinonasal disease. Arch Otolaryngol Head Neck Surg. 1991;117:422-426.
27. Jones JW, Parsons DS, Cuyler JP. The results of functional endoscopic sinus (FES) surgery on the symptoms of patients with cystic fibrosis. Int J Pediatr Otorhinolaryngol. 1993; 28:25-32.
28. Stammberger H. Indications for endoscopic sinus surgery. In: Functional Endoscopic Sinus Surgery. Philadelphia: BC Decker; 1991:273-281.
29. Alhaddad S. Anesthesia for endoscopic sinus surgery. In: Levine HL, Mark M, eds. Endoscopie Sinus Surgery. 1st ed. New York: Thieme; 1993:91-104.
30. Kennedy DW. Functional endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg. 1985;111:643-649.
31. King V von B. Upper respiratory disease, sinusitis and polyposis. Clinical Reviews in Allergy. 1991;9:143-157.
32. Crockett DM, McGill TJ, Healy GB, et al. Nasal and paranasal sinus surgery in children with cystic fibrosis. Ann Otol Rhinol Laryngol. 1987;96:367-372.